Toxic effect of an antitumor drug paclitaxel on morphofunctional characteristics of the liver in rats

Bulletin of Experimental Biology and Medicine

Volumn 145, Issue 2, 2008, Pages 263-265

  Ermolaeva, L A ^a   Dubskaya, T Yu ^a   Fomina, T I ^a   Vetoshkina, T V ^a   Gol'dberg, V E ^a  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

Author keywords

Hepatotoxicity; Laboratoryrats; Paclitaxel

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; PACLITAXEL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DEATH; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; EXPERIMENTAL RAT; FEMALE; HISTOPATHOLOGY; LIVER CELL; LIVER FATTY DEGENERATION; LIVER TOXICITY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAXIMUM TOLERATED DOSE; NONHUMAN; RAT; SINGLE DRUG DOSE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL MARKERS; FEMALE; HEPATOCYTES; LIVER; PACLITAXEL; RATS;

RATTUS;

EID: 50649111622     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0066-x     Document Type: Article

References (15)

1. G. G. Avtandilov, Medical Morphometry. Manual [in Russian], Moscow (1990).
2. T. A. Bogush, E. A. Bogush, L. A. Durnov, and A. B. Syrkin, Vopr. Onkol., 47, No. 6, 662-667 (2001).
3. Yu. A. Kinzirskaya, T. A. Bogush, N. V. Ostapchuk, and V. P. Fisenko, Klin. Med., No. 1, 11-16 (2003).
4. V. B. Larionova, E. G. Gorozhanskaya, and O. A. Kolomeitsev, Vestn. Intensivn. Ter., No. 3, 1-10 (2004).
5. B. N. Lyu and B. I. Ismailov, Cancer is the Problem of the XXI Century [in Russian], Almaty (2000), pp. 415-417.
6. N. F. Orel, Ros. Med. Zh., 12, No. 19, 89-91 (2004).
7. E. Pirs, Theoretical and Applied Histochemistry [in Russian], Moscow (1956).
8. M. B. Stenina, Paclitaxel in Clinical Practice [in Russian], Ed. N. I. Perevodchikova, Moscow (2003), pp. 81-117.
9. T. Ganesh, R. C. Guza, S. Bane, and R. Ravindra, Proc. Natl. Acad. Sci. USA, 101, No. 27, 10,006-10,011 (2004).
10. M. L. Jr. Gupta, C. J. Bode, G. I. Georg, and R. H. Himes, Ibid., 100, No. 11, 6394-6397 (2003).
11. S. B. Horwitz, D. Cohen, S. Rao, et al., J. Natl. Cancer Inst. Monogr., 15, 55-61 (1993).
12. A. Manzano, T. Roig, J. Bermudez, and R. Bartrons, Am. J. Physiol., 271, No. 6, 1957-1962 (1996).
13. H. Minami, Y. Ohe, S. Niho, et al., J. Clin. Oncol., 22, No. 14, 2901-2908 (2004).
14. M. O. Trielli, P. R. Andreassen, F. B. Lacroix, and R. L. Margolis, J. Cell Biol., 135, No. 3, 689-700 (1996).
15. R. Vaclavikova, P. Soucek, L. Svobodova, et al., Drug Metab. Dispos., 32, No. 6, 666-674 (2004).